LATE BREAKING ABSTRACT: Biomarker-driven access to crizotinib in ALK, MET or ROS1 positive (+) malignancies in adults and children: The French natio...

Date 26 September 2015
Event European Cancer Congress 2015
Session Early Drug Development I
Topics Drug Development
Presenter Vassal, G.